Isolation, culture and propagation of natural killer cells

Michael Magee , Lazar N. Vujanovic , Lisa H. Butterfield , Nikola L. Vujanovic
Natural Killer Cells#R##N#Basic Science and Clinical Application 125 -135

2010
Alpha fetoprotein hypersensitizes human natural killer cells to interleukin-2-mediated activation (TUM2P.885)

Lazar Vujanovic , Lisa Butterfield , Elizabeth Stahl
Journal of Immunology 192

2014
New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

Lazar Vujanovic , Lisa H Butterfield
Current opinion in investigational drugs 11 ( 12) 1399 -1408

14
2010
Cross-Talk Between NK Cells and Adenovirally-Engineered Dendritic Cell Vaccines

Jennifer C. Landsberg , Nikola L. Vujanovic , Lazar Vujanovic , Lisa H. Butterfield
The FASEB Journal 22

2008
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.

Uwe M Martens , William Sharfman , Robert L Ferris , Suzanne L Topalian
Journal for ImmunoTherapy of Cancer 9 ( 6)

57
2021
Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer

Lisheng Ge , Dejan Baskic , Per Basse , Lazar Vujanovic
Cancer Epidemiology, Biomarkers & Prevention 18 ( 11) 2913 -2922

13
2009
Dendritic Cell Vaccines for Immunotherapy of Cancer: Challenges in Clinical Trials

Lazar Vujanovic , Lisa H. Butterfield
Targeted Cancer Immune Therapy 159 -172

2009
Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice

Andrea Sobo-Vujanovic , Lazar Vujanovic , Albert B. DeLeo , Fernando Concha-Benavente
Cancer immunology research 4 ( 5) 441 -451

16
2016
Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer–Cell Activation and Subsequent Cell Death

Lazar Vujanovic , Elizabeth C. Stahl , Angela D. Pardee , David A. Geller
Cancer Immunology Research 5 ( 6) 493 -502

10
2017
Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer

Dejan Baskic , Lazar Vujanovic , Nebojsa Arsenijevic , Theresa L. Whiteside
Head and Neck-journal for The Sciences and Specialties of The Head and Neck 35 ( 3) 388 -398

12
2013
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.

Lisa H. Butterfield , Begonya Comin-Anduix , Lazar Vujanovic , Yohan Lee
Journal of Immunotherapy 31 ( 3) 294 -309

100
2008
Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses.

Lazar Vujanovic , Jian Shi , John M Kirkwood , Walter J Storkus
OncoImmunology 3 ( 8)

11
2014
Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells

Lazar Vujanovic , Elizabeth Stahl , Lisa H Butterfield
Journal for ImmunoTherapy of Cancer 2 ( S3) 178

2014
Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability

Lazar Vujanovic , Elizabeth Stahl , Angela Pardee , Simon Watkins
Journal for ImmunoTherapy of Cancer 3 ( 2) 289

2015
Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity

LeeAnn T. Blalock , Jennifer Landsberg , Michelle Messmer , Jian Shi
OncoImmunology 1 ( 3) 287 -357

21
2012
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10

Lazar Vujanovic , Wenners Ballard , Stephen H. Thorne , Nikola L. Vujanovic
OncoImmunology 1 ( 4) 448 -457

28
2012